Bioton (FRA:7U5) GF Score: 61/100 (As of Jul. 08, 2026) — Near Median


FRA:7U5 Bioton SA FRA:7U5
61 GF Score
Price €0.88
GF Value €1.05
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bioton GF Score?

Bioton FRA:7U5 -0.57% 61 GF Score is 61 as of Jul. 08, 2026, which is 9% above its 10-year median of 56.00. GuruFocus rates FRA:7U5 with a GF Score™ of 61/100 and a GF Value™ of €1.05 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Bioton has the GF Score of 61, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 4/10
3. Growth Rank : 2/10
4. GF Value Rank : 10/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Bioton might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Bioton  (FRA:7U5) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Bioton GF Score Related Terms

FRA:7U5 vs VRTX, REGN, ALNY: GF Score Comparison

For the Biotechnology subindustry, Bioton's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioton GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's GF Score distribution charts can be found below:

* The bar in red indicates where Bioton's GF Score falls into.


FRA:7U5
61GF Score
Bioton SA FRA:7U5
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 61 mean?
Bioton (FRA:7U5) has a GF Score of 61 as of Jul. 08, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bioton and its competitors. This is near median its historical median of 56.00. Over the past decade, Bioton's GF Score has ranged from 20.00 to 72.00.
Is Bioton's GF Score too high?
Bioton's current GF Score of 61 is near median its 10-year median of 56.00. Over the past 10 years, this metric has ranged from a low of 20.00 to a high of 72.00. Overall, Bioton has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioton's GF Score compare to VRTX and REGN?
Bioton's GF Score of 61 can be compared against companies in the Biotechnology industry. Historically, Bioton's own GF Score has ranged from 20.00 to 72.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bioton and its competitors. Bioton's current GF Score is 61, which is near median its own 10-year median of 56.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioton stock overvalued right now?
Based on GuruFocus' analysis, Bioton (FRA:7U5) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.05, compared to a current price of €0.88 — trading 16.6% below its estimated fair value. The current GF Score is 61, which is near median its 10-year median of 56.00. Bioton's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Bioton (FRA:7U5), the current GF Score is 61 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioton (FRA:7U5) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of €0.88 is trading 16.6% below its estimated GF Value™ of €1.05. GuruFocus considers Bioton to be Modestly Undervalued.

Key valuation signals for FRA:7U5:

  • GF Score: 61 (near median its 10-year median of 56.00)
  • GF Value™: €1.05 vs. price of €0.88 (16.6% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the FRA:7U5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioton Business Description

Other Exchanges BIO:Poland
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
61GF Score

Get the complete analysis for FRA:7U5

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.88
Price
€1.05
GF Value